Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Undecanoate (Nebido) in Hypogonadal Men
NCT00220298Phase 3Completed
- Sponsor
- Bayer
- Start
- Feb 2003
- Primary completion
- Oct 2007
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of testosterone undecanoate in Hypogonadism, sponsored by Bayer. Primary endpoint: Efficacy and Safety of long term treatment with TU under real-life conditions. Started Feb 2003; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT00220298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00220298.